Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000007

Chairperson & CEO sold 9,500 shares at an average $518.03 ($4,921,275)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

21 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-09 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $146.03 $1,387,285 9,630 D
2026-03-09 Sale : show line 2 in the form 10b5-1 −200 $500.05 $100,010 9,430 D
2026-03-09 Sale : show line 3 in the form 10b5-1 −244 $509.49 $124,317 9,186 D
2026-03-09 Sale : show line 4 in the form 10b5-1 −701 $510.81 $358,075 8,485 D
2026-03-09 Sale : show line 5 in the form 10b5-1 −896 $511.73 $458,514 7,589 D
2026-03-09 Sale : show line 6 in the form 10b5-1 −603 $512.88 $309,269 6,986 D
2026-03-09 Sale : show line 7 in the form 10b5-1 −676 $513.65 $347,226 6,310 D
2026-03-09 Sale : show line 8 in the form 10b5-1 −565 $514.90 $290,919 5,745 D
Open-market sales · 9,500 sh · avg $518.03 · $4,921,275

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-09 Exercise or conversion : show line 22 in the form 10b5-1 Stock Option −9,500 183,000 D
Loading xslF345X05/primarydocument.xml…